End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27 USD | -.--% | -.--% | -.--% |
Evolution of the average Target Price on Thermo Fisher Scientific Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Thermo Fisher Scientific Inc.
Jefferies & Co. | |
HSBC | |
Raymond James | |
Redburn Atlantic | |
Deutsche Bank Securities | |
TD Cowen | |
Bernstein | |
JPMorgan Chase | |
Morgan Stanley | |
Stifel Nicolaus | |
Goldman Sachs | |
Barclays | |
RBC Capital Markets | |
Wolfe Research | |
Baird | |
Evercore ISI | |
UBS | |
BofA Securities | |
Citigroup | |
KeyBanc Capital Markets | |
Nephron Research | |
Atlantic Equities | |
Morningstar | |
Credit Suisse | |
Cowen | |
SVB Securities LLC | |
Wells Fargo Securities | |
SVB Leerink | |
BTIG | |
Argus | |
Benchmark Capital | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- TMO Stock
- TMOD Stock
- Consensus Thermo Fisher Scientific Inc.